1. Home
  2. Live Updates
  3. Pressure enabled drug delivery

Live Breaking News & Updates on Pressure enabled drug delivery

Stay informed with the latest breaking news from Pressure enabled drug delivery on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pressure enabled drug delivery and stay connected to the pulse of your community

TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors

– Accomplished industry veteran brings deep strategic and operational expertise

...

Copenhagen , Køavn- , Denmark , Liselotte-hyveled , Mary-szela , Twitter , Nasdaq , Linkedin , Novo-nordisk , Trisalus-life-sciences , Copenhagen-business-school , Copenhagen-university

TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call

Call Scheduled for Wednesday, May 15, 2024, at 9:00 a.m. ET

...

Nasdaq , Trisalus-life-sciences , Twitter , Linkedin , Trisalus-life , Pressure-enabled-drug-delivery , Infusion-system , Pancreatic-retrograde-venous-infusion-system , Pressure-enabled-regional-immuno-oncology , Markets ,

Short Interest in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) Drops By 15.3%

Short Interest in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) Drops By 15.3%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Deerfield-management-companylp-series , News-ratings-for-trisalus-life-sciences-daily , Institutional-trading-of-trisalus-life-sciences , Trisalus-life-sciences-trading-down , Trisalus-life-sciences-inc , Context-capital-management , Nasdaq , Wolverine-asset-management , Shaolin-capital-management , Trisalus-life-sciences , Get-free-report

TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives

TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Mumbai , Maharashtra , India , London , City-of , United-kingdom , Hong-kong , San-francisco , California , Shanghai

TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives

TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Hong-kong , London , City-of , United-kingdom , Mumbai , Maharashtra , India , New-york , United-states , San-francisco , California , Shanghai

TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update

Reported revenues of $5.7 million in 4Q23, up 77% over prior year



Full year revenues of $18.5 million, up 49% over prior year



Gross Margin of 90% in 4Q23 and 86% for full year



CMS...

Texas , United-states , Mary-szela , Intrahepatic-cholangiocarcinoma , Trisalus-life-sciences , Centers-for-medicare-medicaid-services , Linkedin , Academic-oncology-centers , University-of-texas-md-anderson-cancer-center , Nasdaq , Company-annual-report-on-form , Twitter

TriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific Meeting

– New safety and feasibility data from Phase 1/1b PERIO-03 trial for locally advanced pancreatic cancer supports further development of the novel TriSalus Infusion System for therapeutic delivery...

Texas , United-states , Trisalu-trinav , Stevenc-katz , Linkedin , Centers-for-medicare-medicaid-services , University-of-texas-md-anderson-cancer-center , Nasdaq , Twitter , Society-of-interventional-radiology-annual-scientific-meeting , Current-medical-research , Trisalus-life-sciences

TriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial Results

TriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Exchange-commission , Trisalus-life-sciences , Nasdaq , Linkedin , Twitter , See-the-company-quarterly-report-on-form , Salus-life-sciences , Unaudited-fourth-quarter , Full-year , Infusion-system , Pressure-enabled-drug-delivery

TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumors

DENVER--(BUSINESS WIRE)--Feb 29, 2024--

United-states , Mary-szela , Trinav-smartvalve , Stevenc-katz , Centers-for-medicare , Current-medical-research , Nasdaq , Linkedin , Twitter , Trisalus-life-sciences , Salus-life-sciences , Chief-executive-officer

Haystack Oncology, developer of Haystack MRD™, and TriSalus Life Sciences collaborate in connection with the clinical development of TriSalus' TLR9 agonist in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and pancreatic adenocarcinoma

BALTIMORE, Jan. 22, 2024 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics company and developer of best-in-class personalized MRD technology , has entered a research collaboration with...

Helsinki , Eteläuomen-läi , Finland , Hamburg , Germany , United-states , Maryland , Baltimore , Americans , Dan-edelstein , Steven-katz , Research-use